2018
Sex differences in the nicotinic acetylcholine and dopamine receptor systems underlying tobacco smoking addiction
Verplaetse T, Morris ED, McKee SA, Cosgrove KP. Sex differences in the nicotinic acetylcholine and dopamine receptor systems underlying tobacco smoking addiction. Current Opinion In Behavioral Sciences 2018, 23: 196-202. PMID: 31341936, PMCID: PMC6656369, DOI: 10.1016/j.cobeha.2018.04.004.Peer-Reviewed Original ResearchSmoking addictionNicotinic acetylcholine receptor systemReceptor systemNon-nicotine factorsRecent imaging literatureSex differencesNicotine replacement therapyDopamine receptor systemAcetylcholine receptor systemNicotine-motivated behaviorsFuture medication developmentNicotine-related reinforcementTobacco smokingImaging findingsNicotine administrationReplacement therapyDopaminergic systemNeurochemical mechanismsNicotinic acetylcholineDopamine systemMedication developmentLines of evidenceSmokingImaging literatureWomen
2014
Prospective Evaluation of Factors Predicting Nicotine Withdrawal Symptoms Among Korean Americans
Kim SS, Fang H, McKee SA, Ziedonis D. Prospective Evaluation of Factors Predicting Nicotine Withdrawal Symptoms Among Korean Americans. The Journal Of Smoking Cessation 2014, 11: 154-162. PMID: 26413165, PMCID: PMC4582669, DOI: 10.1017/jsc.2014.20.Peer-Reviewed Original ResearchMinnesota Nicotine Withdrawal ScaleKorean American smokersNicotine withdrawal symptomsWithdrawal symptomsMore withdrawal symptomsAmerican smokersGreater riskNicotine replacement therapySmoking cessation interventionCessation interventionsProspective evaluationReplacement therapyDisturbed sleepIntensive treatmentTwo-armWithdrawal ScaleAbstinence statusSymptomsWeekly assessmentsSmokersFirst weekWomenSmokingHigh rateWeeks
2013
A preliminary study on the effect of combined nicotine replacement therapy on alcohol responses and alcohol self‐administration
Udo T, Harrison EL, Shi J, Tetrault J, McKee SA. A preliminary study on the effect of combined nicotine replacement therapy on alcohol responses and alcohol self‐administration. American Journal On Addictions 2013, 22: 590-597. PMID: 24131167, PMCID: PMC3934424, DOI: 10.1111/j.1521-0391.2013.12014.x.Peer-Reviewed Original ResearchConceptsSelf-administration periodNicotine nasal sprayHeavy drinking smokersNasal sprayNicotine patchAlcohol responsesPriming drinkSerum nicotine levelsPlacebo-controlled studyNicotine replacement therapySubjective alcohol responsesPositive subjective responsesNumber of drinksPlacebo administrationReplacement therapyPriming doseSmoking relapseAlcohol consumptionPlacebo conditionPatch applicationNicotine levelsClinical settingPilot studySmokersSubjective responses
2012
Longitudinal Associations Between Smoking Cessation Medications and Alcohol Consumption Among Smokers in the International Tobacco Control Four Country Survey
McKee SA, Young‐Wolff K, Harrison EL, Cummings KM, Borland R, Kahler CW, Fong GT, Hyland A. Longitudinal Associations Between Smoking Cessation Medications and Alcohol Consumption Among Smokers in the International Tobacco Control Four Country Survey. Alcohol Clinical And Experimental Research 2012, 37: 804-810. PMID: 23240586, PMCID: PMC3610791, DOI: 10.1111/acer.12041.Peer-Reviewed Original ResearchConceptsSmoking cessation medicationsCessation medicationsNicotine replacementAlcohol consumptionInternational Tobacco Control Four Country SurveyFour Country SurveyNicotine replacement therapyReduced alcohol consumptionSmoking statusReplacement therapySmoking cessationMedication effectsMedicationsSmoking behaviorEpidemiological investigationsCountry SurveySmokersAvailable evidenceLongitudinal associationsBaseline drinkingEpidemiological sampleFrequent drinkingTelephone surveyVareniclineSmoking
2006
A Controlled Trial of Naltrexone Augmentation of Nicotine Replacement Therapy for Smoking Cessation
O’Malley S, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL, Blakeslee A, Meandzija B, Romano-Dahlgard D, Wu R, Makuch R, Jatlow P. A Controlled Trial of Naltrexone Augmentation of Nicotine Replacement Therapy for Smoking Cessation. JAMA Internal Medicine 2006, 166: 667-674. PMID: 16567607, DOI: 10.1001/archinte.166.6.667.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, CutaneousAdministration, OralAmbulatory CareDose-Response Relationship, DrugDouble-Blind MethodDrug Therapy, CombinationFemaleHumansLinear ModelsMaleMiddle AgedNaltrexoneNarcotic AntagonistsNicotineNicotinic AgonistsSmoking CessationSubstance Withdrawal SyndromeSurveys and QuestionnairesTreatment OutcomeWeight GainConceptsNicotine patch therapyNicotine patchPatch therapyDouble-blind placebo-controlled trialHigher continuous abstinence ratesLow-dose naltrexone therapyNaltrexone hydrochlorideWeight gainTreatment completersOral naltrexone hydrochlorideOutpatient research centerWeight-concerned smokersContinuous abstinence ratesPlacebo-controlled trialPrimary end pointSecond-line treatmentNicotine replacement therapyNaltrexone augmentationNaltrexone therapyPlacebo groupQuit dateTreat analysisAbstinence ratesReplacement therapySmoking cessation